Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters
Protoplasma · 2026
DOI: 10.1007/s00709-025-02096-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protoplasma, 2026. Verfasst von Reem Hasaballah Alhasani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Withania, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: This study was supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R213), Princess Nourah bint Abdulrahma….
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is an extensive metabolic disorder that imposes significant health and economic problems worldwide. It is characterized by chronic hyperglycemia, insulin resistance, and systemic inflammation. T2DM is linked with an increased risk of terrible difficulties, including cardiovascular disease, neuropathy, and nephropathy. The developing proofs suggest that natural compounds such as Ashwagandha (Withania somnifera) may have therapeutic potential due to their anti-inflammatory, antioxidant, and glucose-regulating properties. Ashwagandha is a traditional medicinal herb that is rich in withanolides and has demonstrated efficacy in previous studies; however, its comprehensive role in mitigating T2DM-related complications is underexplored. The current study seeks to assess the anti-inflammatory and antidiabetic effects of Ashwagandha in a high-fat diet (HFD) and low-dose streptozotocin (STZ)-induced T2DM mouse model. We have selected male C57BL/6 mice, which were allocated into four experimental groups, i.e. controls, STZ-induced diabetic controls, diabetic mice treated with Ashwagandha (200 mg/kg), and diabetic mice treated with metformin. The mice were treated for 8 weeks and then we assisted histological changes in pancreatic and hepatic tissues, with analysis of molecular markers of inflammation and glucose metabolism, and biochemical parameters such as blood glucose, insulin levels, lipid profiles, and oxidative stress markers. We have found a significant reduction in systemic inflammation, enhanced glucose tolerance, improved insulin sensitivity, and restored function of pancreatic β-cell. Furthermore, Ashwagandha treatment is predicted to relieve hepatic steatosis and adipose tissue inflammation by altering key oxidative stress and inflammatory pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Biology, Jamoum University College, Umm Al-Qura University, 21955, Makkah, Saudi Arabia.
- Faculty of Science, Department of Biology, University of Tabuk, 47913, Tabuk, Saudi Arabia.
- College of Medicine, Fahad Bin Sultan University, 47721, Tabuk, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, 71491, Tabuk, Saudi Arabia.
Förderung
- This study was supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R213), Princess Nourah bint Abdulrahma…
Zitieren
APA
Alhasani, R. H., Alsharif, I., Albalawi, A. E., Albalawi, F. E., Mohammedsaleh, Z. M., Saleh, F. M., Barnawi, J., Alshammari, N. S., Basoudan, N. S., Ghouth, N. M., Almohaimeed, H. M., Hasan, T., Ellatif, S. A., & Soliman, M. H. (2026). Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters. Protoplasma. https://doi.org/10.1007/s00709-025-02096-4
Vancouver
Alhasani RH, Alsharif I, Albalawi AE, Albalawi FE, Mohammedsaleh ZM, Saleh FM, et al. Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters. Protoplasma. 2026. doi:10.1007/s00709-025-02096-4
BibTeX
@article{Alhasani2026,
author = {Alhasani, Reem Hasaballah and Alsharif, Ifat and Albalawi, Aishah E and Albalawi, Fahad Eid and Mohammedsaleh, Zuhair M and Saleh, Fayez M and Barnawi, Jameel and Alshammari, Nashmiah S and Basoudan, Nasreen S and Ghouth, Nahlah M and Almohaimeed, Hailah M and Hasan, Tabinda and Ellatif, Sawsan Abd and Soliman, Mona H},
title = {Anti-inflammatory and anti-diabetic role of Ashwagandha (Withania somnifera) in a type 2 diabetes mellitus mouse model: a study using histological, molecular, and pathological parameters},
journal = {Protoplasma},
year = {2026},
doi = {10.1007/s00709-025-02096-4}
}
EUVIMED